Dr. Brenda Weigel named Chair of CureSearch Scientific Advisory Council 

Bethesda, MD – August 26, 2020 – CureSearch for Children’s Cancer announces that Brenda Weigel, MD, has been appointed as the new chair of the CureSearch Scientific Advisory Council. The Council is comprised of best-in-class pediatric oncologists who set the academic priorities for CureSearch research initiatives and evaluate projects on scientific merit.  

Dr. Weigel is the Director of the Division of Pediatric Hematology/Oncology and is a professor cross-appointed at the University of Minnesota’s Masonic Cancer Center and the Department of Pediatrics. She is also the Co-Director of the Sarcoma Program for the Masonic Cancer Center and medical director of the Masonic Cancer Center Clinical Trials Office. 

“CureSearch is uniquely positioned to break down the barriers and accelerate the pace of drug development for pediatric cancer.” said Dr. Weigel. “I am privileged, honored and excited to be the next council chair and support this expert team of scientific advisors who are united in the goal of delivering new treatment options for the children that need them most.”   

“Dr. Weigel has dedicated her career to the pursuit of innovative therapeutics for pediatric cancer, experience that will be an asset to CureSearch and our focus on drug development,” said Caitlyn Barrett, PhD, National Director of Research & Programs for CureSearch. “Her contributions to groups like the National Cancer Institute and the Children’s Oncology Group will foster essential collaborations between CureSearch and the dedicated scientists driving safer and more effective therapies into clinical trials.” 

The Council is composed of experts from world-renown pediatric cancer research institutions such as the Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center and Children’s Hospital of Los Angeles. The Council also includes representation from the U.S. Food and Drug Administration. 

To learn more about the CureSearch Scientific Advisory Council, visit https://curesearch.org/Advisory-Councils 

______________________________________________________________________________ 

###

About CureSearch 

CureSearch for Children’s Cancer works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch focuses on advancing the strongest research out of the laboratory and into clinical trials and development, where better, less-toxic treatments can quickly help children. 

For more information, visit curesearch.org, follow CureSearch on Twitter @curesearch or join the conversation on Facebook at facebook.com/curesearch. 

______________________________________________________________________________ 

Media Contact: Tiffani Copeland 

Senior Vice President, Development & Communications 

CureSearch for Children’s Cancer 

Email: tiffani.copeland@curesearch.org 

The post Dr. Brenda Weigel named Chair of CureSearch Scientific Advisory Council appeared first on CureSearch for Children's Cancer.

Media Contact:
Bailey Singletary
240-235-2204
Bailey.Singletary@curesearch.org

Trent Demulling and David Whan Join CureSearch for Children’s Cancer
Board of Directors

BETHESDA, MD – August 14, 2020 – CureSearch for Children’s Cancer is pleased to announce the appointment of Trent Demulling and David Whan to its Board of Directors, effective immediately. Demulling and Whan join a dedicated team focused on accelerating the pace of drug development for children, adolescents and young adults diagnosed with cancer.

Demulling, who will serve as Board Treasurer, is the Senior Vice President and Chief Financial Officer at Kiewit Corporation, one of the largest and most respected construction and engineering organizations in North America. Before joining Kiewit, Demulling held leadership positions at KPMG LLP and PricewaterhouseCoopers LLP.

Whan most recently served as Vice President, Chief Human Resources Officer for TopBuild Corporation. Previously, he was Director, Global Talent Development and HR Strategy for Deere & Company. Over twenty years at Deere, he held multiple global human resources positions, overseeing strategy, policy, governance, and industrial relations. Today, Whan advises CEOs, boards and other executives on human resources topics.

“We’re thrilled to add these two experts in their fields to our world class leadership team including our board, advisory councils and committees,” said Kay Koehler, CureSearch President & CEO. “This extraordinary level of volunteer leadership will propel us forward to make the greatest impact for children with cancer.”

“Trent and David bring decades of diverse executive and philanthropic experience to the organization. Their strong sense of community, professional connections and wide spheres of influence will no doubt greatly benefit the families we serve,” said Hank Adams, Executive Vice President for Kiewit Infrastructure Group and Chair of the CureSearch Board Nominating Committee.

CureSearch Directors provide outstanding executive leadership, experience and expertise from the areas of business, finance, medical research, and more. Many directors have experienced childhood cancer in their own families or with close friends, and they understand the challenges facing patients and families today.

To learn more about CureSearch’s Board of Directors, visit curesearch.org/Board-of-Directors.

###

About CureSearch for Children’s Cancer
CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, Md., works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch focuses on advancing the strongest research out the laboratory and into clinical trials and development, where better, less-toxic treatments can quickly help children. To learn more visit curesearch.org.

The post CureSearch for Children’s Cancer Announces Board of Directors Additions appeared first on CureSearch for Children's Cancer.